Sarcomas Completed Phase 2 Trials for Sorafenib (DB00398)

Also known as: Sarcoma / Malignant neoplasm of soft tissues / Malignant soft tissue neoplasm / Malignant soft tissue neoplasm NOS / Soft tissue cancer / Sarcoma NOS / Soft tissue sarcoma

IndicationStatusPhase
DBCOND0041813 (Sarcomas)Completed2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT00217620S0505 Sorafenib in Treating Patients With Advanced Soft Tissue SarcomasTreatment
NCT00837148Sorafenib and Dacarbazine in Soft Tissue SarcomaTreatment